Neurology® Podcast

Dr. Jason Crowell speaks with Dr. John Noseworthy on his NEJM article on preserving the physician-patient relationship, which you can read here: https://www.nejm.org/doi/full/10.1056/NEJMsr1912662.

Dr. Halley Alexander talks with Dr. Emma Foster about her Neurology paper discussing that antiepileptic drugs are not independently associated with cognitive dysfunction. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

Dr. Jason Crowell speaks with Denise Roland of the Wall Street Journal about her story on an obscure model driving down drug costs. You can read their paper in the Wall Street Journal here: https://www.wsj.com/articles/obscure-model-puts-a-price-on-good-healthand-drives-down-drug-costs-11572885123.

This month’s Delayed Recall highlights 6 interviews on encephalopathies from the March and April 2013 Delayed Recall episodes. You’ll hear about encephalopathies caused by endocrine disorders, by electrolyte disorders, by liver and kidney failure, and by other organ failure. The other interviews cover encephalopathies caused by systemic disease, such as encephalopathies caused by drugs or miscellaneous causes, including vitamin deficiencies and autoimmune disorders.

Dr. Stacey Clardy talks with Dr. Robert Silbergleit and Dr. Jaideep Kapur about anticonvulsant medications for status epilepticus. You can read Dr. Silbergleit and Dr. Kapur's paper in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMoa1905795.

Dr. Stacey Clardy talks with Dr. Ken Tyler about infectious encephalitis and arthropod-borne infections in 2019.

In the first interview, Dr. Teshamae Monteith talks with Dr. Francesca Puledda about her paper on clinical and phenotypical descriptions of visual snow syndrome patients. In the second interview, Dr. Jason Crowell talks with Ed Silverman about the settlement over allegations a patient charity helped drug makers pay kickbacks to Medicare patients over MS drugs. You can read the STAT article here: https://www.statnews.com/2019/11/20/patient-charity-allegations-ms-drug-makers-kickbacks/. 

In the first segment, Dr. Jason Crowell talks with Dr. Timothy Yu about patient-customized oligonucleotide therapy for a rare genetic disease. In the second part of the podcast, Dr. Jeffrey Burns talks with Dr. Amy Sanders about her implementation update on quality improvement in dementia care. You can read Dr. Yu’s paper in the NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa1813279. Disclosures can be found at Neurology.org. CME Opportunity: Listen to this week’s Neurology Podcast and earn 0.5 AMA PRA Category 1 CME Credits™ by answering the multiple-choice questions in the online Podcast quiz.

This month’s Delayed Recall highlights episodes on CTE and head trauma. Dr. Jason Crowell talks with Dr. Jesse Mez on his work on chronic traumatic encephalopathy and American football players, from the August 29, 2017. The next segment, from January 21, 2020, features Dr. Jeff Ratliff interviewing Dr. Charles Bernick on MRI biomarkers in boxers and MMA fighters. Next, from April 3, 2018, Dr. Lee Goldstein discusses teen concussion and early tauopathy with Dr. Jeff Ratliff. Finally, we feature the November 6, 2012 interview between Dr. Jeff Kutcher and Dr. Everett Lehman about his paper on NFL players and neurologic causes of death.

Dr. Jason Crowell talks with Dr. Daniel Hartung about his qualitative study on drug prices for MS.